C-cure ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 10.3% 12.8% 10.5% 22.4%  
Credit score (0-100)  0 22 17 22 4  
Credit rating  N/A BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 1,411 193 23.5 -26.7  
EBITDA  0.0 984 240 23.5 -26.7  
EBIT  0.0 184 240 23.5 -26.7  
Pre-tax profit (PTP)  0.0 172.8 219.1 19.5 -32.6  
Net earnings  0.0 133.8 167.3 15.2 -26.8  
Pre-tax profit without non-rec. items  0.0 173 219 19.5 -32.6  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 588 755 770 621  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 4.1  
Balance sheet total (assets)  0.0 1,986 1,327 936 658  

Net Debt  0.0 -656 -676 -934 -600  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 1,411 193 23.5 -26.7  
Gross profit growth  0.0% 0.0% -86.3% -87.8% 0.0%  
Employees  0 1 1 0 0  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 1,986 1,327 936 658  
Balance sheet change%  0.0% 0.0% -33.2% -29.5% -29.6%  
Added value  0.0 984.4 239.9 23.5 -26.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 -800 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 -1.0  

Profitability 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 13.1% 124.1% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 9.3% 14.5% 2.1% -3.3%  
ROI %  0.0% 28.5% 33.8% 3.0% -3.8%  
ROE %  0.0% 22.8% 24.9% 2.0% -3.8%  

Solidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 29.6% 56.9% 82.3% 94.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -66.6% -281.6% -3,970.6% 2,252.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 291.1%  

Liquidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 1.5 2.4 5.7 17.9  
Current Ratio  0.0 1.5 2.4 5.7 17.9  
Cash and cash equivalent  0.0 655.6 675.5 934.2 604.6  

Capital use efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 647.1 773.8 770.2 621.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 984 240 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 984 240 0 0  
EBIT / employee  0 184 240 0 0  
Net earnings / employee  0 134 167 0 0